Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Halozyme Therapeutics Inc (NASDAQ:HALO)

13.94
Delayed Data
As of Apr 28
 -0.05 / -0.36%
Today’s Change
7.70
Today|||52-Week Range
15.20
+41.09%
Year-to-Date
Largest transactions by value over  
NameTypeDateShares
traded
Share
price
Transaction
value
Since
transaction
Stelzer Laurie D
Chief Financial Officer & Senior Vice President
Sale2/03/20179,085$12.26$111.4K+13.70%
Countouriotis Athena
Chief Medical Officer & Senior Vice President
Sale2/03/20176,900$12.26$84.6K+13.70%
Leonhardt Harry J
Chief Compliance Officer, SVP & General Counsel
Sale2/03/20176,198$12.26$76.0K+13.70%
Torley Helen I
President & Chief Executive Officer
Sale6/30/20167,044$8.63$60.8K+61.53%
Leonhardt Harry J
Chief Compliance Officer, SVP & General Counsel
Sale4/13/20172,583$12.81$33.1K+8.82%
Countouriotis Athena
Chief Medical Officer & Senior Vice President
Sale6/30/2016107$8.63$923.41+61.53%
Third Security Llc
Director
Gift5/04/201620,202$0.00$0.00+40.81%
Bizzari Jean Pierre
Director
Gift5/04/201620,202$0.00$0.00+40.81%
Daly James M
Director
Gift5/04/201620,202$0.00$0.00+40.81%
Falberg Kathryn E
Director
Gift5/04/201620,202$0.00$0.00+40.81%
Page of 3